Back to today’s briefing

Story perspectives

Trump's Tylenol Claims Spark Controversy Amid Safety Reassurances

10/8/2025

23 2 Full Breakdown

Summary

Story summary

On October 7, 2025, President Trump claimed acetaminophen (Tylenol) could reduce autism rates.
He urged pregnant women to avoid it, though no evidence links the drug to autism.
Health officials, including Secretary Robert F. Kennedy Jr., supported the statements.
The American College of Obstetrics and Gynecology reaffirmed Tylenol's safety during pregnancy.
Vermont's Department of Health labeled the claims false.

History

Historical Context

Acetaminophen, first synthesized in the 19th century, became widely used as a pain reliever, particularly during pregnancy, with over 60% of pregnant women using it by 2016. Despite endorsements from major health organizations, misinformation about its safety persists, notably claims linking it to autism made by President Trump in 2025, highlighting the ongoing need for accurate health communication.

1 of 2

Story summary

On October 7, 2025, President Trump claimed acetaminophen (Tylenol) could reduce autism rates.
He urged pregnant women to avoid it, though no evidence links the drug to autism.
Health officials, including Secretary Robert F. Kennedy Jr., supported the statements.
The American College of Obstetrics and Gynecology reaffirmed Tylenol's safety during pregnancy.
Vermont's Department of Health labeled the claims false.

1 / 2